Drug intelligence / Profile preview

purified corticotropin gel

Development stage
Approved
Lead developer
ANI Pharmaceuticals
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Subcutaneous
01

Overview

Purified Cortrophin Gel is a prescription pharmaceutical formulation containing purified porcine-derived adrenocorticotropic hormone (ACTH 1-39) in gelatin for prolonged activity, supplied as a sterile, injectable gel[1][5][12]. **Mechanism of Action:** It stimulates the adrenal cortex via the melanocortin 2 receptor (MC2R), leading to increased production and secretion of endogenous adrenocortical hormones, including glucocorticoids and mineralocorticoids, which modulate inflammation and immune responses[1][5][12][2][7]. **Indications:** - Management of acute exacerbations/flairs in multiple sclerosis - Infantile spasms (seizures in children under age 2) - Adjunctive treatment for rheumatic disorders: psoriatic arthritis, rheumatoid arthritis (including juvenile), ankylosing spondylitis, acute gouty arthritis - Collagen diseases like systemic lupus erythematosus and systemic dermatomyositis (polymyositis) - Severe skin diseases (e.g., Stevens-Johnson syndrome, severe psoriasis), atopic dermatitis (eczema), and serum sickness - Severe allergic and inflammatory ophthalmic diseases (e.g., allergic conjunctivitis, keratitis, uveitis, optic neuritis) - Symptomatic sarcoidosis - Reduction of proteinuria in nephrotic syndrome (idiopathic or lupus origin, without uremia)[3][8][10][12][5][13] **It is not indicated for: scleroderma, osteoporosis, fungal infections, ocular herpes simplex, recent surgery, stomach ulcers, congestive heart failure, uncontrolled hypertension, primary adrenocortical insufficiency, adrenocortical hyperfunction, or hypersensitivity to porcine proteins.

Brand names
Purified Cortrophin Gel
Other names
corticotropin gelrepository corticotropincorticotropin (ACTH)
02

Targets

MC4R (Melanocortin 4 receptor)MC1R (Melanocortin Type 1 Receptor)MC2R (Adrenocorticotropic Hormone Receptor)MC3R (Melanocortin Receptor Type 3)MC5R (Melanocortin 5 Receptor)

Beyond the preview

Go deeper on purified corticotropin gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on purified corticotropin gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call